CareRx Corporation (TSX: CRRX)
Canada
· Delayed Price · Currency is CAD 2.340
-0.010 (-0.43%)
Jul 19, 2024, 4:00 PM EDT
CareRx Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Year Ending | TTM | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
| Revenue | 369.07 | 370.75 | 381.73 | 262.63 | 162.2 | 124.63 | Upgrade
|
| Revenue Growth (YoY) | -2.86% | -2.88% | 45.35% | 61.92% | 30.15% | 4.80% | Upgrade
|
| Cost of Revenue | 263.53 | 266.05 | 271.79 | 187.35 | 115.14 | 85.24 | Upgrade
|
| Gross Profit | 105.54 | 104.7 | 109.93 | 75.28 | 47.05 | 39.38 | Upgrade
|
| Selling, General & Admin | 97.83 | 97.87 | 102.55 | 70.52 | 47.98 | 41.49 | Upgrade
|
| Operating Expenses | 97.83 | 97.87 | 102.55 | 70.52 | 47.98 | 41.49 | Upgrade
|
| Operating Income | 7.71 | 6.83 | 7.38 | 4.76 | -0.93 | -2.11 | Upgrade
|
| Interest Expense | -12.97 | -13.86 | -14.89 | -14.65 | -9.69 | -24.35 | Upgrade
|
| Interest & Investment Income | 1.01 | 1.26 | 0.28 | 0.06 | 0.06 | - | Upgrade
|
| Net Interest Expenses | -11.96 | -12.6 | -14.61 | -14.59 | -9.63 | -24.35 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.26 | -0.13 | 5.24 | -2.24 | 2.64 | 2.18 | Upgrade
|
| EBT Excluding Unusual Items | -4.51 | -5.91 | -1.98 | -12.08 | -7.92 | -24.28 | Upgrade
|
| Merger & Restructuring Charges | -1.58 | -1.45 | -5 | -8.06 | -11.4 | -3.16 | Upgrade
|
| Impairment of Goodwill | - | - | -22.52 | - | - | -8 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | -2.71 | - | 0.76 | - | Upgrade
|
| Asset Writedown | -0.71 | -0.71 | -1.81 | - | - | - | Upgrade
|
| Other Unusual Items | -1.16 | -1.53 | -1.87 | -3.6 | 0.25 | -4.14 | Upgrade
|
| Pretax Income | -7.96 | -9.6 | -35.9 | -23.74 | -18.3 | -39.58 | Upgrade
|
| Income Tax Expense | -4.19 | -4.19 | -1.54 | -1.01 | -0.12 | 6.1 | Upgrade
|
| Earnings From Continuing Operations | -3.77 | -5.41 | -34.35 | -22.73 | -18.18 | -45.68 | Upgrade
|
| Earnings From Discontinued Operations | - | - | - | - | -0.08 | 16.36 | Upgrade
|
| Net Income to Company | -3.77 | -5.41 | -34.35 | -22.73 | -18.26 | -29.32 | Upgrade
|
| Net Income | -3.77 | -5.41 | -34.35 | -22.73 | -18.26 | -29.32 | Upgrade
|
| Net Income to Common | -3.77 | -5.41 | -34.35 | -22.73 | -18.26 | -29.32 | Upgrade
|
| Shares Outstanding (Basic) | 58 | 57 | 48 | 35 | 20 | 11 | Upgrade
|
| Shares Outstanding (Diluted) | 58 | 57 | 48 | 35 | 20 | 11 | Upgrade
|
| Shares Change (YoY) | 17.43% | 20.49% | 36.54% | 72.00% | 84.63% | 7.83% | Upgrade
|
| EPS (Basic) | -0.06 | -0.09 | -0.72 | -0.65 | -0.90 | -2.67 | Upgrade
|
| EPS (Diluted) | -0.06 | -0.09 | -0.72 | -0.65 | -0.90 | -2.67 | Upgrade
|
| Free Cash Flow | 27.28 | 22.65 | 12.29 | 1.92 | -1.33 | 3.27 | Upgrade
|
| Free Cash Flow Per Share | 0.47 | 0.39 | 0.26 | 0.06 | -0.07 | 0.30 | Upgrade
|
| Gross Margin | 28.60% | 28.24% | 28.80% | 28.66% | 29.01% | 31.60% | Upgrade
|
| Operating Margin | 2.09% | 1.84% | 1.93% | 1.81% | -0.57% | -1.69% | Upgrade
|
| Profit Margin | -1.02% | -1.46% | -9.00% | -8.65% | -11.26% | -23.53% | Upgrade
|
| Free Cash Flow Margin | 7.39% | 6.11% | 3.22% | 0.73% | -0.82% | 2.62% | Upgrade
|
| EBITDA | 22.88 | 22.89 | 21.74 | 16.96 | 8.35 | 7.22 | Upgrade
|
| EBITDA Margin | 6.20% | 6.17% | 5.69% | 6.46% | 5.15% | 5.79% | Upgrade
|
| D&A For EBITDA | 15.17 | 16.07 | 14.35 | 12.21 | 9.27 | 9.33 | Upgrade
|
| EBIT | 7.71 | 6.83 | 7.38 | 4.76 | -0.93 | -2.11 | Upgrade
|
| EBIT Margin | 2.09% | 1.84% | 1.93% | 1.81% | -0.57% | -1.69% | Upgrade
|
Source: S&P Capital IQ. Standard template.